As new technologies become widely accessible, competitive advantage will increasingly depend on
how organisations combine science, proprietary data, talent and technology. Senior leaders discuss
what will differentiate tomorrow's most successful discovery organisations.
Where technology is creating genuine scientific advantage.
Proprietary data versus increasingly accessible models and platforms.
Building differentiated discovery capabilities.
Combining internal expertise with external innovation ecosystems.
Where pharmaceutical R&D leaders should invest next.
Drug Discovery and Development
Leadership and Strategy
Geraldine Low
Lead Product Research & Designer, Artificial Intelligence and Machine Learning at GSK
Digi-Tech Pharma & AI 2027
Digi-Tech Pharma & AI 2027
Confirm your details
and get access to the full content
Kindly confirm your (Name, Job Title, Company Name, Email address) details in the
below link. Please feel free to edit
your details if needed.